Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 21.71M PLN in the quarter ending March 31, 2026, with 3.21% growth. This brings the company's revenue in the last twelve months to 88.38M, up 92.83% year-over-year. In the year 2025, Ryvu Therapeutics had annual revenue of 87.70M, down -13.98%.

• Revenue (ttm): 88.38M
• Revenue Growth: +92.83%
• P/S Ratio: 4.02
• Revenue / Employee: 387.63K
• Employees: 228
• Market Cap: 355.59M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.70M	-14.26M	-13.98%
Dec 31, 2024	101.96M	34.67M	51.51%
Dec 31, 2023	67.30M	-1.14M	-1.67%
Dec 31, 2022	68.44M	33.02M	93.25%
Dec 31, 2021	35.41M	-1.54M	-4.16%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 12, 2026

Data Sources Report a data error